These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24791771)

  • 1. The role of general practitioners in the continued success of the National Cervical Screening Program.
    Munro A; Pavicic H; Leung Y; Westoby V; Steel N; Semmens J; O'Leary P
    Aust Fam Physician; 2014 May; 43(5):293-6. PubMed ID: 24791771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Cervical Smears Performed by General Practitioners on the Cervical Cancer Screening Rate of their Female Patients: A Claim Database Analysis and Cross-Sectional Survey.
    Favre J; Rochoy M; Raginel T; Pelletier M; Messaadi N; Deken-Delannoy V; Duhamel A; Berkhout C
    J Womens Health (Larchmt); 2018 Jul; 27(7):933-938. PubMed ID: 29583084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HPV vaccine and cervical cancer prevention in general practice. Survey conducted among general practitioners in the French departments of Eure-et-Loir and Cher].
    Pélissier G; Bastides F
    Rev Prat; 2008 Dec; 58(19 Suppl):25-31. PubMed ID: 19253788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General practitioners' perception of risk factors for cervical cancer development: consequences for patient education.
    Baay MF; Verhoeven V; Peremans L; Avonts D; Vermorken JB
    Patient Educ Couns; 2006 Aug; 62(2):277-81. PubMed ID: 16533588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV vaccination: effects on cervical screening.
    Kothari A
    Nurs Times; 2014 Jun 11-17; 110(24):19-21. PubMed ID: 25007499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motivators for women to attend cervical screening: the influential role of GPs.
    O'Connor M; Murphy J; Martin C; O'Leary J; Sharp L;
    Fam Pract; 2014 Aug; 31(4):475-82. PubMed ID: 24927724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Summary of the practice guideline 'Prevention and early diagnosis of cervical cancer' of the Dutch College of General Practitioners].
    Janssen PG; Boomsma LJ; Buis PA; Collette C; Boukes FS; Goudswaard AN
    Ned Tijdschr Geneeskd; 2009; 153():A517. PubMed ID: 20051149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
    Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
    Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination.
    Drolet M; Boily MC; Greenaway C; Deeks SL; Blanchette C; Laprise JF; Brisson M
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):641-52. PubMed ID: 23549400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era.
    de Blasio BF; Neilson AR; Klemp M; Skjeldestad FE
    J Public Health (Oxf); 2012 Dec; 34(4):539-47. PubMed ID: 22707556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing cervical cancer in the Latina population.
    Flores K; Bencomo C
    J Womens Health (Larchmt); 2009 Dec; 18(12):1935-43. PubMed ID: 20044855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
    McCaffery K; Irwig L
    J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of cervical screening in the era of human papillomavirus vaccination.
    Canfell K
    Sex Health; 2010 Sep; 7(3):359-67. PubMed ID: 20719228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening.
    Wong C; Berkowitz Z; Saraiya M; Wideroff L; Benard VB
    Sex Health; 2010 Sep; 7(3):338-45. PubMed ID: 20719225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: an Australian perspective.
    Farnsworth A
    Acta Cytol; 2011; 55(4):307-12. PubMed ID: 21791898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program.
    Brotherton JM; Leask J; Jackson C; McCaffery K; Trevena LJ
    Sex Health; 2010 Sep; 7(3):291-8. PubMed ID: 20719217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pap smear tests in general practice. An update.
    Ward J; Sanson-Fisher R
    Aust Fam Physician; 1992 Apr; 21(4):465-6. PubMed ID: 1530474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast and cervical cancer screening disparities associated with disability severity.
    Horner-Johnson W; Dobbertin K; Andresen EM; Iezzoni LI
    Womens Health Issues; 2014; 24(1):e147-53. PubMed ID: 24439941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.